141 related articles for article (PubMed ID: 34193385)
21. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
22. Prospective Surveillance for Breast Cancer-Related Arm Lymphedema: A Systematic Review and Meta-Analysis.
Rafn BS; Christensen J; Larsen A; Bloomquist K
J Clin Oncol; 2022 Mar; 40(9):1009-1026. PubMed ID: 35077194
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients - Randomised controlled trial.
Abdelhamid MI; Bari AA; Farid MI; Nour H
Int J Surg; 2020 Mar; 75():174-178. PubMed ID: 32059974
[TBL] [Abstract][Full Text] [Related]
24. Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review.
Gebruers N; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():117-22. PubMed ID: 27019287
[TBL] [Abstract][Full Text] [Related]
25. American Cancer Society Lymphedema Workshop. Workgroup I: Treatment of the axilla with surgery and radiation--preoperative and postoperative risk assessment.
Leitch AM; Meek AG; Smith RA; Boris M; Bourgeois P; Higgins S; Pressman PI; Stevens J; Stevens RE
Cancer; 1998 Dec; 83(12 Suppl American):2877-9. PubMed ID: 9874415
[No Abstract] [Full Text] [Related]
26. Lymphedema following axillary lymph node dissection for breast cancer.
Sakorafas GH; Peros G; Cataliotti L; Vlastos G
Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
[TBL] [Abstract][Full Text] [Related]
27. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
28. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
29. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
30. The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C; Yang B; Zuo WS; Zheng G; Yang L; Zheng MZ
PLoS One; 2016; 11(2):e0150285. PubMed ID: 26919589
[TBL] [Abstract][Full Text] [Related]
31. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Nos C; Lesieur B; Clough KB; Lecuru F
Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570
[TBL] [Abstract][Full Text] [Related]
32. A new technique that complements sentinel lymph node biopsy: lymph node dissection under the intercostobrachial nerves in early-stage breast cancer.
Li J; Jia S; Zhang W; Zhang Y; Qiu F; Xue J; Gu X
Clin Breast Cancer; 2013 Jun; 13(3):212-8. PubMed ID: 23380290
[TBL] [Abstract][Full Text] [Related]
33. Lymphedema and quality of life in survivors of early-stage breast cancer.
Beaulac SM; McNair LA; Scott TE; LaMorte WW; Kavanah MT
Arch Surg; 2002 Nov; 137(11):1253-7. PubMed ID: 12413312
[TBL] [Abstract][Full Text] [Related]
34. The changing role of axillary treatment in breast cancer: Who will remain at risk for developing arm morbidity in the future?
Lopez Penha TR; van Roozendaal LM; Smidt ML; Boersma LJ; von Meyenfeldt MF; Voogd AC; Heuts EM
Breast; 2015 Oct; 24(5):543-7. PubMed ID: 26051795
[TBL] [Abstract][Full Text] [Related]
35. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
36. Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment.
Soran A; Aydin C; Harlak A; Vogel VG; Johnson R
Breast J; 2005; 11(5):370-1. PubMed ID: 16174167
[No Abstract] [Full Text] [Related]
37. Precipitating factors for lymphedema following surgical treatment of breast cancer: implications for patients undergoing axillary lymph node dissection.
Dayangac M; Makay O; Yeniay L; Aynaci M; Kapkac M; Yilmaz R
Breast J; 2009; 15(2):210-1. PubMed ID: 19292814
[No Abstract] [Full Text] [Related]
38. Lymphedema in breast cancer patients: declining, but awareness still needed.
J Support Oncol; 2006 Feb; 4(2):71. PubMed ID: 16499122
[No Abstract] [Full Text] [Related]
39. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
40. Axillary dissection for breast cancer.
Olszewski WL
Lymphology; 2002 Mar; 35(1):41-2. PubMed ID: 11939573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
